Apogee Therapeutics, Inc. (APGE) ownership: Top institutional holder: T. Rowe Price Investment Management, Inc. ($867.03M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 10300984.00 | $867.03M | 2026-03-31 |
| FMR LLC | 9262291.00 | $779.61M | 2026-03-31 |
| Venrock Adviser, LLC | 8493321.00 | $714.88M | 2026-03-31 |
| WELLINGTON MANAGEMENT GROUP LLP | 4375703.00 | $368.30M | 2026-03-31 |
| BlackRock, Inc. | 4085651.00 | $343.89M | 2026-03-31 |
| RTW INVESTMENTS, LP | 2782097.00 | $234.17M | 2026-03-31 |
| VANGUARD GROUP INC | 2857824.00 | $215.71M | 2025-12-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2502095.00 | $210.60M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-09 | |
| Sell | null | 2026-06-09 |
Back to APGE overview · APGE earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.